Caris Life Sciences (CAI) Free Cash Flow (2024 - 2026)

Caris Life Sciences' Free Cash Flow history runs 3 years deep, the most recent figure standing at $33.0 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 205.52% year-over-year to $33.0 million in Q1 2026; TTM through Mar 2026 was $147.5 million, a 202.62% increase from a year earlier, with the FY2025 full-year figure at $83.2 million, up 132.8% from the prior year.
• Free Cash Flow eased to $33.0 million in Q1 2026 per CAI's latest filing, from $56.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $56.0 million in Q4 2025 and bottomed at -$65.3 million in Q3 2024.
• The 3-year median for Free Cash Flow is $3.2 million (2025), against an average of $538000.0.
• Biggest YoY gain for Free Cash Flow was 218.62% in 2025; the steepest drop was 184.79% in 2025.
• Year by year, Free Cash Flow stood at -$47.2 million in 2024, then jumped by 218.62% to $56.0 million in 2025, then sank by 41.02% to $33.0 million in 2026.
• Per Business Quant, the three latest CAI Free Cash Flow figures stand at $33.0 million (Q1 2026), $56.0 million (Q4 2025), and $55.3 million (Q3 2025).